This clinical trial examines whether early, empirical, high-dose cryoprecipitate, in addition to standard major hemorrhage protocols, would improve survival in the first 28 days after hospital admission following injury.

Comments

You must log in or register to comment.

(￣□￣;)

There's nothing here…

1 point (+1, −0)

Short URL:

http://blurb.social/77678

Health

Welcome to /f/health! This blurb is dedicated to all aspects of well-being. Join discussions on physical and mental health, nutrition, fitness, and medical advancements. Our rules: 1. Be respectful. 2. Stay on topic. 3. Provide reliable sources. 4. Avoid medical advice. 5. No self-diagnosis or promotion. Engage in informed discussions and explore the world of health with us!

Created June 22, 2023
Subscribe via RSS

Moderators

joeyrobert

See full list